Regentis Biomaterials Ltd. (RGNT)
NYSE · Healthcare
Regentis Biomaterials Ltd. Operating Income 2023–2025
Regentis Biomaterials Ltd. annual/quarterly operating income history and growth rate from 2023 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Regentis Biomaterials Ltd. annual operating income for 2025 was -8.6 M, a 1024.79% decrease from 2024.
- Regentis Biomaterials Ltd. annual operating income for 2024 was 932000, a 148.27% decrease from 2023.
- Regentis Biomaterials Ltd. annual operating income for 2023 was -1.9 M.
No data available.
Regentis Biomaterials Ltd. Operating Income — FAQ
Regentis Biomaterials Ltd. (RGNT) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Regentis Biomaterials Ltd.'s operating income?
Regentis Biomaterials Ltd. (RGNT) reported operating income of -$9M for fiscal 2025.
Where can I see RGNT's operating income history?
The chart and table above show Regentis Biomaterials Ltd.'s operating income by year and by quarter, including the growth rate.